Positive preliminary results reported in phase 1b re-treatment trial of QLT091001

Clinically meaningful improvements in visual fields and visual acuity have been reported in preliminary results from a phase 1b clinical trial of repeated treatments of oral QLT091001 in subjects with Leber congenital amaurosis or retinitis pigmentosa, according to a press release from QLT. Specifically, the international multicenter trial targeted Leber congenital amaurosis or retinitis pigmentosa due to inherited genetic mutations in retinal pigment epithelium (RPE65) or lecithin:retinol acyltransferase (LRAT), the release said. The extension study included patients who been treated with a single course of QLT091001 in a previous phase (Read more...)